Amid uncertainty over payouts for infringement for design patents, Columbia Sportswear's recent multimillion-dollar trial win in a case over cold-weather gear has been a source of hope for patent owners, and is among a handful of cases that may signal where the law is headed.
Suit concerned technology to route customer calls to appropriate support staff.
Court finds internet search engine violated intellectual property code by selling ad space next to pages produced by trademarked search terms.
Controversial move would block online distribution of pirated digital content.
Judge declares four Corixa patents unenforceable due to inequitable conduct.
Claims employees misappropriated secrets.
Paychex claims E-chx infringed trademark and hired former employees in violation of non-compete agreements.
New copyright tribunal would would met out stiffer punishment to infringers.
Company takes ownership of patents and pays inventor $7.9 million.
Union head proposes reducing 20-year patent protection period and integrating all prescription drugs into a revised Canada Health Act.
Speed of approval would depend on complexity of drug, executive predicts.
Grantham University pulls trademark "America's Online University" under pressure from America Online.
Media Markt agrees remove a device that Macromedia claims circumvents DVD copyrights.
Common system would greatly reduce applications and processing time across 21-nation region.
Caterpillar seeks a temporary restraining order to block Tuesday's scheduled release of "George and the Jungle 2."
Case concerns right of U.S. health information provider NDCHealth to demand a licence to the marketing database of rival IMS Health.
More than 15,000 unprocessed applications have built up as government shuffles agency handling of registrations.
Government wants trademark owners to help pool resources to deal with infringements.
System would allow consumers to download songs onto a mobile phone and share them without breaking copyright laws.
Dispute centers on ownership of Stolichnaya and Moskovskaya trademarks outside Russia.
In a setback for large pharma and biotech companies, alternative route could be used to approve the first generation of generic biotechnology drugs.